Bladder Cancer - Results from #140

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review. November 5, 2021

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer. November 4, 2021

Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer. November 4, 2021

BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer. November 4, 2021

Validation of a novel assessment tool identifying proficiency in Transurethral Bladder Tumour Resection: The OSATURBS assessment tool. November 4, 2021

Comparing Preoperative Chemotherapy Regimens in Patients with Muscle-Invasive Bladder Cancer - Expert Commentary November 3, 2021

The Significant Role of Depression in Elderly Patients with Bladder Cancer. November 3, 2021

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit. November 3, 2021

Intracorporeal versus Extracorporeal Neobladder after Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. November 2, 2021

Defining radical cystectomy using the ICD-10 procedure coding system. November 2, 2021

Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States. November 1, 2021

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. November 1, 2021

Expression of FOXA1 Is Associated with the Tumor-Infiltrating M2 Macrophage, Cytotoxic T Lymphocyte, and Effect of Chemotherapy in Bladder Cancer. October 29, 2021

Improving Guideline Adherence in Urology. October 29, 2021

Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer. October 28, 2021

Cachexia and bladder cancer: clinical impact and management. October 28, 2021

Utility of Blue Light Cystoscopy for Post-BCG Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons. October 27, 2021

Comparison of clinicopathologic and oncological outcomes between Trans-Urethral En Bloc (TUEB) Resection and Conventional Trans-Urethral Resection of Bladder Tumor (cTURBT): a systematic review, meta-analysis and network meta-analysis with focus on Differ October 27, 2021

Role of Lymphadenectomy During Radical Cystectomy for Non-muscle Invasive Bladder Cancer: Results From a Multi-Institutional Experience. October 27, 2021

Efficacy of Adding Panitumumab to Dose-Dense MVAC Chemotherapy in Patients with Advanced Urothelial Cancer - Expert Commentary October 26, 2021

Page 8 of 417

email news signup